Is This the Time to Introduce Minimal Residual Disease in Multiple Myeloma Clinical Practice?
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-2841
Full Text
Open PDFAbstract
Available in full text
Date
March 9, 2015
Authors
Publisher
American Association for Cancer Research (AACR)